Your browser doesn't support javascript.
loading
Understanding mutational effects in digenic diseases.
Gazzo, Andrea; Raimondi, Daniele; Daneels, Dorien; Moreau, Yves; Smits, Guillaume; Van Dooren, Sonia; Lenaerts, Tom.
Afiliação
  • Gazzo A; Interuniversity Institute for Bioinformatics in Brussels, ULB-VUB, Boulevard du Triomphe CP 263, 1050 Brussels, Belgium.
  • Raimondi D; MLG, Université Libre de Bruxelles, Boulevard du Triomphe, CP 212, 1050 Brussels, Belgium.
  • Daneels D; Center for Medical Genetics, Reproduction and Genetics, Reproduction Genetics and Regenerative Medicine, Vrije Universiteit Brussel, UZ Brussel, Laarbeeklaan 101, 1090 Brussels, Belgium.
  • Moreau Y; Interuniversity Institute for Bioinformatics in Brussels, ULB-VUB, Boulevard du Triomphe CP 263, 1050 Brussels, Belgium.
  • Smits G; MLG, Université Libre de Bruxelles, Boulevard du Triomphe, CP 212, 1050 Brussels, Belgium.
  • Van Dooren S; Structural Biology Brussels, Vrije Universiteit Brussel, 1050 Brussels, Belgium.
  • Lenaerts T; Interuniversity Institute for Bioinformatics in Brussels, ULB-VUB, Boulevard du Triomphe CP 263, 1050 Brussels, Belgium.
Nucleic Acids Res ; 45(15): e140, 2017 Sep 06.
Article em En | MEDLINE | ID: mdl-28911095
To further our understanding of the complexity and genetic heterogeneity of rare diseases, it has become essential to shed light on how combinations of variants in different genes are responsible for a disease phenotype. With the appearance of a resource on digenic diseases, it has become possible to evaluate how digenic combinations differ in terms of the phenotypes they produce. All instances in this resource were assigned to two classes of digenic effects, annotated as true digenic and composite classes. Whereas in the true digenic class variants in both genes are required for developing the disease, in the composite class, a variant in one gene is sufficient to produce the phenotype, but an additional variant in a second gene impacts the disease phenotype or alters the age of onset. We show that a combination of variant, gene and higher-level features can differentiate between these two classes with high accuracy. Moreover, we show via the analysis of three digenic disorders that a digenic effect decision profile, extracted from the predictive model, motivates why an instance was assigned to either of the two classes. Together, our results show that digenic disease data generates novel insights, providing a glimpse into the oligogenic realm.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Epistasia Genética / Doenças Genéticas Inatas / Mutação Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Epistasia Genética / Doenças Genéticas Inatas / Mutação Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article